ChABC infusions into medial prefrontal cortex, but not posterior parietal cortex, improve the performance of rats tested on a novel, challenging delay in the touchscreen TUNL task.


Journal

Learning & memory (Cold Spring Harbor, N.Y.)
ISSN: 1549-5485
Titre abrégé: Learn Mem
Pays: United States
ID NLM: 9435678

Informations de publication

Date de publication:
06 2020
Historique:
received: 29 06 2019
accepted: 27 02 2020
entrez: 17 5 2020
pubmed: 18 5 2020
medline: 18 8 2021
Statut: epublish

Résumé

Perineuronal nets (PNNs) are specialized extracellular matrix structures that surround subsets of neurons throughout the central nervous system (CNS). They are made up of chondroitin sulfate proteoglycans (CSPGs), hyaluronan, tenascin-R, and many other link proteins that together make up their rigid and lattice-like structure. Modulation of PNNs can alter synaptic plasticity and thereby affect learning, memory, and cognition. In the present study, we degraded PNNs in the medial prefrontal (mPFC) and posterior parietal (PPC) cortices of Long-Evans rats using the enzyme chondroitinase ABC (ChABC), which cleaves apart CSPGs. We then measured the consequences of PNN degradation on spatial working memory (WM) with a trial-unique, non-matching-to location (TUNL) automated touchscreen task. All rats were trained with a standard 6 sec delay and 20 sec inter-trial interval (ITI) and then tested under four different conditions: a 6 sec delay, a variable 2 or 6 sec delay, a 2 sec delay with a 1 sec ITI (interference condition), and a 20 sec delay. Rats that received mPFC ChABC treatment initially performed TUNL with higher accuracy, more selection trials completed, and fewer correction trials completed compared to controls in the 20 sec delay condition but did not perform differently from controls in any other condition. Rats that received PPC ChABC treatment did not perform significantly differently from controls in any condition. Posthumous immunohistochemistry confirmed an increase in CSPG degradation products (C4S stain) in the mPFC and PPC following ChABC infusions while WFA staining intensity and parvalbumin positive neuron number were decreased following mPFC, but not PPC, ChABC infusions. These findings suggest that PNNs in the mPFC play a subtle role in spatial WM, but PNNs in the PPC do not. Furthermore, it appears that PNNs in the mPFC are involved in adapting to a challenging novel delay, but that they do not play an essential role in spatial WM function.

Identifiants

pubmed: 32414940
pii: 27/6/222
doi: 10.1101/lm.050245.119
pmc: PMC7233150
doi:

Substances chimiques

Chondroitin Sulfate Proteoglycans 0
Chondroitin ABC Lyase EC 4.2.2.20

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

222-235

Subventions

Organisme : CIHR
ID : 125984
Pays : Canada

Informations de copyright

© 2020 Anderson et al.; Published by Cold Spring Harbor Laboratory Press.

Références

Brain Res. 1996 Mar 4;711(1-2):102-11
pubmed: 8680852
Science. 2009 Sep 4;325(5945):1258-61
pubmed: 19729657
Neurobiol Learn Mem. 2010 Oct;94(3):341-52
pubmed: 20692356
Exp Neurol. 2004 Aug;188(2):309-15
pubmed: 15246831
Psychopharmacology (Berl). 2015 Dec;232(23):4371-82
pubmed: 26359226
PLoS One. 2012;7(3):e32747
pubmed: 22427872
Nat Neurosci. 2001 May;4(5):465-6
pubmed: 11319553
Psychopharmacology (Berl). 2015 Nov;232(21-22):3935-45
pubmed: 26173611
Proc Natl Acad Sci U S A. 2010 Feb 23;107(8):3340-5
pubmed: 19884507
Acta Neuropathol. 2005 Oct;110(4):393-401
pubmed: 16133543
Nature. 2002 Apr 11;416(6881):636-40
pubmed: 11948352
Nature. 2013 Dec 12;504(7479):272-6
pubmed: 24336286
J Neurophysiol. 2016 Sep 1;116(3):1049-54
pubmed: 27306678
eNeuro. 2018 Dec 28;5(6):
pubmed: 30627657
J Neurosci. 2016 Nov 9;36(45):11459-11468
pubmed: 27911749
Neuroscience. 1994 Jan;58(2):371-88
pubmed: 7512240
J Neuropathol Exp Neurol. 2008 Mar;67(3):189-99
pubmed: 18344910
J Neurosci. 2014 May 7;34(19):6647-58
pubmed: 24806690
Neurobiol Learn Mem. 2015 Nov;125:85-92
pubmed: 26265370
Psychopharmacology (Berl). 2017 Jan;234(2):211-222
pubmed: 27725997
Proc Natl Acad Sci U S A. 2013 May 28;110(22):9130-5
pubmed: 23671099
Learn Mem. 2017 May 15;24(6):262-266
pubmed: 28507036
J Neurosci. 2015 Mar 11;35(10):4190-202
pubmed: 25762666
Brain. 2018 Aug 1;141(8):2362-2381
pubmed: 29912283
Biotechniques. 2007 Jan;42(1):71-5
pubmed: 17269487
Neuroscience. 2018 Sep 15;388:23-35
pubmed: 30004010
Glia. 1993 Jul;8(3):183-200
pubmed: 7693589
Front Cell Neurosci. 2018 May 30;12:149
pubmed: 29899690
Psychopharmacology (Berl). 2015 Nov;232(21-22):3991-4003
pubmed: 26184010
J Neurosci. 2017 Feb 1;37(5):1269-1283
pubmed: 28039374
Curr Biol. 2016 Jun 20;26(12):1513-1521
pubmed: 27238283
Proc Natl Acad Sci U S A. 2018 Jan 16;115(3):607-612
pubmed: 29279411
Science. 1998 Feb 27;279(5355):1347-51
pubmed: 9478894
Neurobiol Learn Mem. 2019 Mar;159:16-23
pubmed: 30731234
J Neurosci. 2013 Apr 17;33(16):7057-65
pubmed: 23595763
Neuroscience. 2006;139(3):865-76
pubmed: 16500029
Neurobiol Learn Mem. 2013 Mar;101:120-6
pubmed: 23396186
Brain. 2010 Aug;133(Pt 8):2331-47
pubmed: 20566484
Nature. 2004 Apr 15;428(6984):751-4
pubmed: 15085133
Science. 2002 Nov 8;298(5596):1248-51
pubmed: 12424383
Behav Neurosci. 1999 Oct;113(5):941-55
pubmed: 10571477
Learn Mem. 2013 Apr 16;20(5):267-73
pubmed: 23592037
Neuroscience. 2013 Dec 3;253:368-79
pubmed: 24016683
Trends Genet. 2018 Mar;34(3):197-208
pubmed: 29289347
Biol Psychiatry. 2013 Sep 15;74(6):427-35
pubmed: 23790226
Neuroreport. 1992 Oct;3(10):869-72
pubmed: 1421090
Neural Plast. 2016;2016:5214961
pubmed: 26881114
J Biol Chem. 2006 Jun 30;281(26):17789-800
pubmed: 16644727
Brain Behav. 2019 May;9(5):e01265
pubmed: 30912298
Proc Natl Acad Sci U S A. 2018 Oct 2;115(40):9813-9815
pubmed: 30279240
Neurochem Int. 2012 Dec;61(7):963-72
pubmed: 22954428
Proc Natl Acad Sci U S A. 2014 Feb 18;111(7):2800-5
pubmed: 24550310
Cereb Cortex. 2010 Nov;20(11):2712-27
pubmed: 20194688
eNeuro. 2017 Jun 7;4(3):
pubmed: 28593193
Biol Psychiatry. 2015 Sep 15;78(6):396-402
pubmed: 25758057
ACS Cent Sci. 2019 Jul 24;5(7):1223-1234
pubmed: 31404231
J Neurochem. 2010 Sep 1;114(5):1447-59
pubmed: 20584105
J Neurosci Res. 2005 May 15;80(4):539-48
pubmed: 15806566
Cell Rep. 2019 Oct 29;29(5):1099-1112.e4
pubmed: 31665627
Sci Rep. 2016 Nov 23;6:37580
pubmed: 27876866
Neuropsychopharmacology. 2016 Aug;41(9):2206-14
pubmed: 26868058
J Neurosci. 2016 Jun 8;36(23):6312-20
pubmed: 27277807
Neuron. 2015 Oct 7;88(1):33-46
pubmed: 26447571

Auteurs

Michael D Anderson (MD)

Department of Anatomy, Physiology and Pharmacology University of Saskatchewan, Saskatoon, Saskatchewan S7N 5E5, Canada.

John W Paylor (JW)

Department of Psychiatry, University of Alberta, Edmonton, Alberta T6G 2B7, Canada.

Gavin A Scott (GA)

Department of Anatomy, Physiology and Pharmacology University of Saskatchewan, Saskatoon, Saskatchewan S7N 5E5, Canada.

Quentin Greba (Q)

Department of Anatomy, Physiology and Pharmacology University of Saskatchewan, Saskatoon, Saskatchewan S7N 5E5, Canada.

Ian R Winship (IR)

Department of Psychiatry, University of Alberta, Edmonton, Alberta T6G 2B7, Canada.

John G Howland (JG)

Department of Anatomy, Physiology and Pharmacology University of Saskatchewan, Saskatoon, Saskatchewan S7N 5E5, Canada.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH